glp-1 taste in mouth 💡 New research suggests a possible side effect of medications. The study found: ✔️ 48% higher risk of smell or disorders ✔️ 81% higher risk of smell changes ✔️ 52% GLP-1s can enhance taste, or

Many neuroprotective effects remain to be causally associated with anti-inflammatory mechanisms, and some Alzheimers disease mouse models did not respond to semaglutide or tirzepatide, emphasizing that not all neural benefits are consistent across studies

Lancet Diabetes Endocrinol 3(6):450460

Sarah Ackley, a dementia epidemiologist at Brown University wasnt surprised by the failure and told Being Patient that people taking GLP-1s tend to be wealthier, healthier and have better preventative care, which means theyre less at risk of Alzheimers

This review may provide a background to guide future research about the cellular mechanisms of GLP-1-induced feeding inhibition